Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 3]

View source ↗

Summary

Clinical trial update describing a Phase 3 study comparing ocrelizumab with fingolimod for safety and efficacy in children and adolescents with relapsing-remitt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Fingolimod (fingolimod)
• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING